Hepatotoxicity in the critically ill patient. The liver under an acute severe insult;Hepatotoxicidad en el paciente crítico. El hígado bajo agresión aguda grave

Nutricion Hospitalaria

Volumn 23, Issue SUPPL. 2, 2008, Pages 19-24

  Garcia De Lorenzo Y Mateos A ^a   Rodriguez Montes J A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Dysfunction; Injury; Liver

Indexed keywords

CRITICALLY ILL PATIENT; DISEASE SEVERITY; ENERGY METABOLISM; HEPATITIS; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; LIVER TRANSPLANTATION; PROTEIN METABOLISM; REVIEW;

CRITICAL ILLNESS; ENERGY METABOLISM; HUMANS; LIVER; LIVER CIRCULATION; LIVER FAILURE; LIVER FUNCTION TESTS; MULTIPLE ORGAN FAILURE; NUTRITIONAL SUPPORT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 46749140363     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Van der Hoven B, Gommers D, Bakker J. Critical illness and the hepatic microcirculation: a review. Vincent JL (ed.). Yearbook of intensive care and emergency medicine. Springer. Berlin. 2007: 643-650.
2. García de Lorenzo A, Acosta J, Rodríguez Montes JA. Importancia clínica de la traslocación bacteriana. Nutr Hosp 2007; 22 (S2):50-55.
3. Jeschke MG, Herndon DN. The hepatic response to severe injury. Vincent JL (ed.). Yearbook of intensive care and emergency medicine. Springer. Berlin. 2007: 661-665.
4. Derik JP, Poeze M, Van Bijnen AA y cols. Evidence for intestinal and liver epitelial cell injury in the early phase of sepsis. Shock 2007; 28:544-548.
5. Jeschke MG, Micak RP, Finnerty CC, Herndon DN. Changes in liver function and size after severe thermal injury. Shock 2007; 28:172-177.
6. Sakka SG. Assessing liver function. Curr Opin Crit Care 2007; 13:207-214.
7. Xu J, Kim HT, Ma Y y cols. Trauma and hemorrhage-induced acute hepatic insulin resistence: dominant role of tumor necrosis factor (TNF)-(alpha). Endocrinology 2008 [Epub ahead of print].
8. Moshage H. Cytokines and the hepatic acute phase response. J Pathol 1997; 181:257-266.
9. Jeschke MG, Barrow RE, Herndorn DN. Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase response. Crit Care Med 2000; 28:1578-1584.
10. Jeschke MG, Herndon DN, Wolf SE y cols. Hepatocyte growth factor modulates the hepatic acute-phase response in thermally injured rats. Crit Care Med 2000; 28:504-510.
11. Jeschke MG, Barrow RE, Suzuki F y cols. IGF-I/IGFBP-3 equilibrates rations of pro- to anti-inflammatory cytokines, which are predictors for organ function in severely burned pediatric patients. Mol Med 2002; 8:238-246.
12. Klein D, Schubert T, Horch RE y cols. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg 2004; 240:340-349.
13. Barrow RE, Wolfe RR, Dasu MR y cols. The use of beta-adrenergic blockade in preventing trauma-induced hepatomegaly. Ann Surg 2006; 243:115-120.
14. Grau T, Bonet A, Rubio M y cols. Liver dysfunction associated with artificial nutrition in critically ill patient. Crit Care 2007; 11:R10.
15. Charlton M. Branched-Chain amino acid enriched supplements as therapy for liver disease. J Nutr 2006; 136:295S-298S.
16. Kelly DA. Intestinal failure-associated liver disease: what do we know today? Gastroenterology 2006; 130:S70-S77.
17. Cabré E, Gassull MA. Nutrition in liver disease. Curr Opin Clin Nutr Metab Care 2005; 8:545-551.
18. Stratton RJ, Smith TR. Role of enteral and parenteral nutrition in the patient with gastrointestinal and liver disease. Best Practice & Research Clinical Gastroenterology 2006; 20:441-466.